“These data reinforce that the Amulet device is safe and effective, and also, importantly, that it's helping people enjoy their lives and worry less about the risk of having a stroke." "Abbott ...

The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...

Within medical devices, diabetes sales were up ... Other than diabetes products, Abbott’s Navitor, TriClip, and Amulet have also been driving the segment growth for the company.